Top Medical News
Yesterday
Cough stress test is more accurate than the 24-hour pad test in diagnosing stress urinary incontinence, a recent study has shown.
2 days ago
Patients with dual negative tests (multiparametric magnetic resonance imaging [MRI] and prostate cancer antigen 3 [PCA3] score) do not present with clinically significant prostate cancer on biopsy, suggesting that biopsy may not be needed in this group, a recent study has shown.
6 days ago
In men with severe erectile dysfunction, primary or secondary penile prosthesis implantation is safe and well-accepted by the patients and their partners, a recent study has found.
6 days ago
Men treated for prostate cancer with worse bowel, sexual and urinary functioning experience greater emotional distress, a recent study has found.
19 May 2018
Parenchymal mass preservation and ischaemia characteristics affect functional recovery following partial nephrectomy, suggests a recent study. Moreover, comorbidities do not appear to be correlated with functional outcomes.
16 May 2018
Dose-dense MVAC (methotrexate, vinblastine, doxorubicin and cisplatin), compared to gemcitabine and cisplatin, is associated with higher complete pathological response and improved survival rates in patients with locally advanced bladder cancer, a recent study has found.
Tristan Manalac, 14 May 2018
While caudal block does not pose serious safety threats, it also does not seem to significantly improve pain control or reduce analgesic use in patients following robot-assisted laparoscopic radical prostatectomy (RARP), a recent Singapore study has shown.
Special Reports
Dr. Joe Lee, 12 Apr 2018

A 70-year-old male with a history of diabetes, hyperlipidaemia and hypertension managed with atenolol presented to his family physician with lower urinary tract symptoms (LUTS). He was prescribed terazosin. Over the course of a year he noticed worsening erectile dysfunction (ED) with difficulty maintaining a hard erection until orgasm.

Dr. Devdatt Palnitkar, 16 Mar 2018
Dr Devdatt Palnitkar of the Palnitkar Hospital, Aurangabad, India, shared a practical guide to treating mild to moderate Overactive bladder (OAB).
02 Nov 2017
Nocturia is the most prevalent of the lower urinary tract symptoms (LUTS) and can cause a significant negative impact on an individual’s quality of life if left untreated.1,2 In a meeting held at University Malaya Medical Centre, Associate Professor Dr Ong Teng Aik shared his insights on the management of nocturia.
Dr Jaime Songco, 31 Oct 2017

Erectile dysfunction (ED) is a common condition defined as the persistent inability to achieve or maintain an erection sufficient for satisfactory sexual performance.1 It is one of the most common complaints in men’s sexual medicine, affecting both physical and psychosocial health and having a significant impact on the patient and partner’s quality of life.1 Moreover, ED is commonly associated with other comorbid conditions, including hypertension, dyslipidaemia and diabetes mellitus.1

Evaluation of ED should include a detailed medical and sexual history of the patient. 1 A discussion of the patient and partner’s preference and treatment goals is essential to better tailor treatment and improve patient satisfaction and adherence to treatment.2 Lifestyle modification and management of risk factors should precede pharmacotherapy, while first-line treatment with oral phosphodiesterase type 5 inhibitors (PDE5i) is well established for the management of patients with ED.1

28 Sep 2017

Benign prostatic hyperplasia (BPH) is characterized by an enlargement of the prostate gland that can lead to compression of the urethra.1 Patients often experience lower urinary tract symptoms (LUTS), which are typically classified as either voiding or storage symptoms.1

Over 60% of men will experience any LUTS.2  Although Asian men typically have smaller prostates compared with Western men, Asians experience similar or higher rates of LUTS that can impact sexual function and quality of life (QoL).1,3

Conference Reports
Audrey Abella, 11 May 2018
Nanotechnology structured water was similarly effective as tadalafil in improving erectile function, suggesting that it could be a potential treatment option for erectile dysfunction (ED), according to a study presented at EAU held in Copenhagen, Denmark.
Audrey Abella, 30 Apr 2018
The selective β3-adrenoreceptor (AR) agonist vibegron showed superior efficacy over placebo for overactive bladder (OAB) treatment and was generally well-tolerated, according to a Japanese study presented at EAU 2018.

Roshini Claire Anthony, 23 Apr 2018

Targeted antibiotic prophylaxis – after a rectal swab to identify specific intestinal flora – does not appear to significantly impact the risk of urinary sepsis following a transrectal ultrasound (TRUS)-guided prostate biopsy, according to a recent study.

Roshini Claire Anthony, 20 Apr 2018

Conservative management appears to be the favoured option in managing non-penetrating renal trauma with urinary extravasation, according to a study presented at EAU 2018.

Christina Lau, 16 Apr 2018

MRI, with or without targeted biopsy, detects more clinically significant prostate cancer and less clinically insignificant prostate cancer than the standard transrectal ultrasonography (TRUS)-guided approach, enabling more than one-quarter of patients to safely avoid a biopsy altogether.

Christina Lau, 12 Apr 2018

Men with nonmetastatic castration-resistant prostate cancer (CRPC) have similar health-related quality of life (HRQoL) with apalutamide given on top of androgen deprivation therapy (ADT) vs ADT alone, according to new data from the SPARTAN (Prostate Androgen Receptor Targeting with ARN-509) trial presented at the European Association of Urology (EAU) 2018 Congress.

Christina Lau, 02 Apr 2018

Patients with urologic cancers are more likely to attempt suicide, highlighting the need for increased psychiatric intervention for these patients at an earlier stage, according to findings presented at the European Association of Urology (EAU) 2018 Congress.